Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
7.07
-0.38 (-5.10%)
At close: Mar 28, 2025, 4:00 PM
7.52
+0.45 (6.32%)
After-hours: Mar 28, 2025, 4:25 PM EDT
Contineum Therapeutics Market Cap
Contineum Therapeutics has a market cap or net worth of $182.91 million as of March 28, 2025.
Market Cap
182.91M
Enterprise Value
-15.59M
1-Year Change
n/a
Ranking
Category
Stock Price
7.07
Market Cap Chart
Since the IPO on April 5, 2024, Contineum Therapeutics's market cap has decreased from $402.09M to $182.91M, a decrease of -54.51%. That is a compound annual growth rate of -55.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2025 | 192.74M | -48.96% |
| Dec 31, 2024 | 377.64M | -6.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |